09/12/2025
Biocon Completes Full Merger Of Biocon Biologics In $5.5 Billion Deal.
Indian biopharmaceutical giant Biocon has announced the full integration of its biosimilar unit, Biocon Biologics, consolidating all of its biosimilars and generics operations under one unified entity.
This move aims to streamline operations, strengthen Biocon’s presence in global biosimilars markets, and enhance value creation for shareholders.
Click link in bio for full story